MENU

ZLAB Stock Tickeron detected bearish Stock Pattern: Head-and-Shoulders Top ZLAB on August 26, 2025, netting in a 21.36% gain over 2 months

A.I.dvisor
at Tickeron.com
Loading...
+21.36% Gain from a Successful pattern Head-and-Shoulders Top
ZLAB - Zai Lab Limited
Tickeron
Ticker: ZLAB
Company: Zai Lab
Gain from shorting: +21.36%
Confirmed: 08/26/25
Succeeded: 10/23/25
Total length: 71 days

On August 13, 2025, A.I.dvisor detected a Head-and-Shoulders Top Pattern (Bearish) for Zai Lab Limited (ZLAB, $35.63). 13 days later, on August 26, 2025, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On October 23, 2025, the stock hit the target price of $26.30 – resulting in a +2 gain for traders who shorted the stock on the pattern detection date.

ZLAB in -5.88% downward trend, declining for three consecutive days on November 18, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ZLAB declined for three days, in of 327 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 50-day moving average for ZLAB moved below the 200-day moving average on October 20, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

The Aroon Indicator for ZLAB entered a downward trend on November 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZLAB advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .

ZLAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.979) is normal, around the industry mean (23.122). P/E Ratio (0.000) is within average values for comparable stocks, (61.014). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.073). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (4.985) is also within normal values, averaging (332.704).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ZLAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZLAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ZLAB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ZLAB showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a service for cancer & autoimmune treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4560 Jinke Road
Phone
+86 2161632588
Employees
2175
Web
https://www.zailaboratory.com